Duke Researchers Find Simpler, More Effective Cancer Vaccine Approach
November 13, 2019
November 13, 2019
DURHAM, North Carolina, Nov. 13 -- Duke Health issued the following news release:
* * *
- Monocytes trigger a better immune response in mice than current dendritic cell vaccines
* * *
Using a precursor to dendritic cells appears to be an efficient and effective way to stimulate the immune system to fight cancer tumors, according to a study in animal and cell models by researchers at the Duke Cancer Institute.
The finding, describe . . .
* * *
- Monocytes trigger a better immune response in mice than current dendritic cell vaccines
* * *
Using a precursor to dendritic cells appears to be an efficient and effective way to stimulate the immune system to fight cancer tumors, according to a study in animal and cell models by researchers at the Duke Cancer Institute.
The finding, describe . . .